# Contineum Therapeutics, Inc. (CTNM)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/CTNM/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -29.61M | $ -28.09M | $ 6.57M | $ 239.66M |
| 2025 | $ 0 | $ -61.41M | $ -56.87M | $ 8.25M | $ 260.99M |
| 2024 | $ 0 | $ -44.42M | $ -35.06M | $ 6.26M | $ 198.07M |
| 2023 | $ 54.06M | $ 24.57M | $ 20.47M | $ 193.19M | $ -67.94M |
| 2022 | $ 0 | $ -8.39M | $ -4.55M | $ 5.85M | $ 39.27M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.03 |
| Liabilities / Eq | 0.04 |
| Current Ratio | 37.17 |

## Other views

- [Metrics](https://sponda.capital/en/CTNM.md)
- [Charts](https://sponda.capital/en/CTNM/charts.md)
- [Compare](https://sponda.capital/en/CTNM/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.